Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title:Subject Index To Volume 1
Volume: 2Issue: 1
Author(s):Science Publishers Bentham and Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Publishers Science and Bentham Science Publishers , Subject Index To Volume 1, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2002; 2 (1) .https://dx.doi.org/10.2174/1568008024606275
DOI https://dx.doi.org/10.2174/1568008024606275 | Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher | Online ISSN 1875-5917 |
Article Metrics
Related Articles
- Biomarkers Linking PCB Exposure and Obesity
Current Pharmaceutical BiotechnologyMultitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal ChemistryAn Overview on 2-arylquinolin-4(1H)-ones and Related Structures as Tubulin Polymerisation Inhibitors
Current Topics in Medicinal ChemistryParathyroid Hormone Determination in Ultrasound-Guided Fine Needle Aspirates Allows the Differentiation between Thyroid and Parathyroid Lesions: Our Experience and Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug TargetsPlant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density
Current Pharmaceutical DesignBio-Activities and Syntheses Developments of Triptolides
Mini-Reviews in Organic Chemistry Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Current Pharmaceutical DesignHeterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry Fork Head Transcription Factors
Current GenomicsTraditional Ayurvedic Treatment Practices by Vaidyas of the Northern Regionof India
Current Indian ScienceMonoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical DesignReproductive Effects of Low-to-Moderate Medical Radiation Exposure
Current Medicinal Chemistry AP5346 (ProLindac™), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer
Current Bioactive Compounds Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer
Current Medicinal Chemistry Melanoma Differentiation Associated Gene-7 (mda-7)/ Interleukin-24 (IL-24), mda-7/IL-24: Current Perspectives on a Unique Member of the IL-10 Family of Cytokines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic AgentsNucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal ChemistryApplying Knowledge of Enzyme Biochemistry to the Prediction of Functional Sites for Aiding Drug Discovery
Current Topics in Medicinal Chemistry
[8]ページ先頭
©2009-2025 Movatter.jp